BEITRAEGE ZUR CHEMIE DER PYRROLPIGMENTE. XX. UNTERSUCHUNGEN UEBER DAS DEPROTONIERUNGSGLEICHGEWICHT UND DIE BILDUNG VON METALLKOMPLEXEN VON GALLENPIGMENT-PARTIALSTRUKTUREN. = CHIMIE DES PIGMENTS DU PYRROLE. XX. ETUDE DE L'EQUILIBRE DE DEPROTONATION ET DE LA FORMATION DE COMPLEXES METALLIQUES AYANT DES STRUCTURES PARTIELLES DE PIGMENTS BILIAIRESFALK H; LEODOLTER A.1978; MONATSH. CHEM.; AUT; DA. 1978; VOL. 109; NO 4; PP. 883-897; ABS. ENG; BIBL. 37 REF.Article

BEITRAEGE ZUR CHEMIE DER PYRROLPIGMENTE. XIV. INTERKONVERSIONSPROZESSE BEI ARYLMETHYLIDENPYRROLINONEN; EIN SPEZIALFALL ATROPISOMERER, STERISCH GEHINDERTER STYROLE. = SUR LA CHIMIE DES PIGMENTS PYRROLIQUES. XIV. PROCESSUS D'INTERCONVERSION DES ARYLMETHYLIDENEPYRROLINONES; UN CAS SPECIAL DE L'ATROPISOMERIE DANS LES STYRENES GENES STERIQUEMENTFALK H; HOFER O; LEODOLTER A et al.1975; MONATSH. CHEM.; OESTERR.; DA. 1975; VOL. 107; NO 4; PP. 907-919; ABS. ANGL.; BIBL. 21 REF.Article

BEITRAEGE ZUR CHEMIE DER PYRROLPIGMENTE. XVIII. PYRROME THENONE-PARTIALSTRUKTUREN VON GALLENPIGMENTEN: STRUKTUR UND EIGENSCHAFTEN IN LOESUNG. = CHIMIE DES PIGMENTS PYRROLIQUES. XVIII. PYRROMETHENONES. STRUCTURE PARTIELLE DES PIGMENTS BILIAIRES. STRUCTURE ET PROPRIETES EN SOLUTIONFALK H; GRUBMAYR K; HOLLBACHER G et al.1977; MONATSH. CHEM.; OESTERR.; DA. 1977; VOL. 108; NO 5; PP. 1113-1130; ABS. ANGL.; BIBL. 30 REF.Article

Citric acid or orange juice for the ¹³C-urea breath test: the impact of pH and gastric emptyingLEODOLTER, A; DOMINGUEZ-MUNOZ, J. E; VON ARNIM, U et al.Alimentary pharmacology & therapeutics. 1999, Vol 13, Num 8, pp 1057-1062, issn 0269-2813Article

European multicentre validation trial of two new non-invasive tests for the detection of Helicobacter pylori antibodies: urine-based ELISA and rapid urine testLEODOLTER, A; VAIRA, D; BAZZOLI, F et al.Alimentary pharmacology & therapeutics. 2003, Vol 18, Num 9, pp 927-931, issn 0269-2813, 5 p.Article

Addition of glucose to a fatty meal delays chylomicrons and suppresses VLDL in healthy subjectsWESTPHAL, S; LEODOLTER, A; KAHL, S et al.European journal of clinical investigation. 2002, Vol 32, Num 5, pp 322-327, issn 0014-2972Article

A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcerLEODOLTER, A; KULIG, M; BRASCH, H et al.Alimentary pharmacology & therapeutics. 2001, Vol 15, Num 12, pp 1949-1958, issn 0269-2813Article

¹³C-urea breath test for the diagnosis of Helicobacter pylori infection: A further simplification for clinical practiceLEODOLTER, A; DOMINGUEZ-MUNOZ, J. E; VON ARNIM, U et al.Scandinavian journal of gastroenterology. 1998, Vol 33, Num 3, pp 267-270, issn 0036-5521Article

Prevalence of Helicobacter pylori infection and gastric mucosal abnormalities in chronic pancreatitisMANES, G; DOMINGUEZ-MUNOZ, J. E; HACKELSBERGER, A et al.The American journal of gastroenterology. 1998, Vol 93, Num 7, pp 1097-1100, issn 0002-9270Article

Prevalence of Helicobacter pylori resistance to several antimicrobial agents in a region of GermanyWOLLE, K; NILIUS, M; LEODOLTER, A et al.European journal of clinical microbiology & infectious diseases (Print). 1998, Vol 17, Num 7, pp 519-521, issn 0934-9723Article

Helicobacter pylori genotypes and expression of gastritis in erosive gastro-oesophageal reflux diseaseLEODOLTER, A; WOLLE, K; PEITZ, U et al.Scandinavian journal of gastroenterology. 2003, Vol 38, Num 5, pp 498-502, issn 0036-5521, 5 p.Article

Prevalence of H. pylori infection in family members of H. pylori positive patients and its influence on the reinfection rate after successful eradication therapy: A two-years follow-upKNIPPIG, C; ARAND, F; LEODOLTER, A et al.Zeitschrift für Gastroenterologie. 2002, Vol 40, Num 6, pp 383-387, issn 0044-2771Article

Helicobacter pylori eradication and gastric ulcer healing -comparison of three pantoprazole-based triple therapiesMALFERTHEINER, P; KIRCHNER, T; KIST, M et al.Alimentary pharmacology & therapeutics. 2003, Vol 17, Num 9, pp 1125-1135, issn 0269-2813, 11 p.Article

α-Catenin expression is decreased in human gastric cancers and in the gastric mucosa of first degree relativesYU, J; EBERT, M. P. A; MIEHLKE, S et al.Gut. 2000, Vol 46, Num 5, pp 639-644, issn 0017-5749Article

Evaluation of an enzyme immunoassay for detecting Helicobacter pylori antigens in human stool samplesAGHA-AMIRI, K; MAINZ, D; PEITZ, U et al.Zeitschrift für Gastroenterologie. 1999, Vol 37, Num 12, pp 1145-1149, issn 0044-2771Conference Paper

Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsiaMALFERTHEINER, P; MÖSSNER, J; FISCHBACH, W et al.Alimentary pharmacology & therapeutics. 2003, Vol 18, Num 6, pp 615-625, issn 0269-2813, 11 p.Article

High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized studyPEITZ, U; SULLIGA, M; WOLLE, K et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 2, pp 315-324, issn 0269-2813, 10 p.Article

Clinical course of laryngo-respiratory symptoms in gastro-oesophageal reflux disease during routine care -a 5-year follow-upJASPERSEN, D; NOCON, M; LABENZ, J et al.Alimentary pharmacology & therapeutics. 2009, Vol 29, Num 11, pp 1172-1178, issn 0269-2813, 7 p.Article

Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagusVIETH, M; KULIG, M; STOLTE, M et al.Alimentary pharmacology & therapeutics. 2006, Vol 23, Num 2, pp 313-319, issn 0269-2813, 7 p.Article

Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease: an analysis based on the ProGERD initiativeKULIG, M; LEODOLTER, A; WILLICH, S. N et al.Alimentary pharmacology & therapeutics. 2003, Vol 18, Num 8, pp 767-776, issn 0269-2813, 10 p.Article

Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD studyKULIG, M; NOCON, M; WILLICH, S. N et al.Journal of clinical epidemiology. 2004, Vol 57, Num 6, pp 580-589, issn 0895-4356, 10 p.Article

Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD studyJASPERSEN, D; KULIG, M; MALFERTHEINER, P et al.Alimentary pharmacology & therapeutics. 2003, Vol 17, Num 12, pp 1515-1520, issn 0269-2813, 6 p.Article

Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care - the ProGERD studyMALFERTHEINER, P; NOCON, M; WILLICH, S. N et al.Alimentary pharmacology & therapeutics. 2012, Vol 35, Num 1, pp 154-164, issn 0269-2813, 11 p.Article